一是第三代氟制冷剂自2024年实行生产配额制后，行业库存消化充分，下游需求旺盛，行业生态改善，产品 价格持续恢复性上涨，毛利大幅提升； 二是公司积极应对市场变化，加强管理、拓展市场、优化结构，实现了主要装置的稳定生产和产销量稳定； 三是公司对存在减值迹象的全资子公司衢州巨化锦纶有限责任公司的相关生产装置计提资产减值准备合计 32,088.96万元，并列入2025年度损益。 巨化股份于1月22日发布了2025年度业绩预增公告，预计2025年度实现归属于上市公司股东的净利润为35.4亿 元到39.4亿元，较上年同期的19.59亿元增加15.8亿元到19.8亿元，同比增长80%到101%。 扣除非经常性损益后，归属于上市公司股东的净利润预计为35.14亿元到39.14亿元，较上年同期的19.03亿元 增加16.11亿元到20.11亿元，同比增长85%到106%。 公司指出，本次业绩大幅增长主要归因于核心产品氟制冷剂价格持续恢复性上涨，以及主要产品产销量稳 定，带动主营业务毛利上升、利润增长。具体原因包括 ...

Core Viewpoint - Hengxing New Materials expects a significant increase in net profit for the year 2025, projecting a range of 57.61 million to 66.24 million yuan, which represents a year-on-year increase of 22.75 million to 31.39 million yuan, or an increase of 65.28% to 90.05% compared to the previous year [2] Group 1: Company Performance - The company is committed to its core business, enhancing capacity utilization and reducing unit costs [2] - The demand in downstream markets, such as green herbicide intermediates and lithium battery electrolyte additives, remains strong, contributing to increased production and sales volume [2] - The production scale effect is evident, driving a substantial improvement in performance [2]

公告表示，公司业绩预增主要由于报告期内渠道销售规模增长、费用投放效率提升、研发创新驱动增长 以及供应链运营模式优化。 北京商报讯（记者 郭秀娟 王悦彤） 1月21日，发布公告称，公司预计2025年归母净利润为3.11亿元至 3.31亿元，比上年同期增长16.06%至23.52%。 ...

Core Viewpoint - Shanghai Electric expects a net profit attributable to shareholders of the parent company for the year 2025 to be between RMB 1.1 billion and RMB 1.32 billion, representing an increase of RMB 350 million to RMB 570 million compared to the previous year, which is an approximate year-on-year increase of 47% to 76% [1] Financial Performance - The projected net profit for 2025 is estimated to be between RMB 1.1 billion and RMB 1.32 billion [1] - This represents an increase of RMB 350 million to RMB 570 million compared to the previous year's statutory disclosure data [1] - The year-on-year growth rate is expected to be approximately 47% to 76% [1]

报告期营业收入较去年同期增长约9%，销售毛利率较去年同期有所提升，毛利额较去年同期增加较 多。 银禧科技（300221）(300221.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净利润1.1亿 元至1.2亿元，同比增长114%至133%;扣除非经常性损益后的净利润1.06亿元至1.16亿元，同比增长107% 至127%。 ...

2025年度，公司预计归属于母公司所有者的净利润较去年同期实现大幅增长，主要受益于国内外收入增 长、股权转让收益。(1)在国内市场，公司在集采获得的市场覆盖优势上，不断深耕和拓宽市场，胰岛 素制剂产品的销量与销售额同步实现大幅增长。(2)在国际市场，公司积极推进国际化战略，在"一带一 路"沿线及新兴市场拓展成效显著，成功赢得了更多国际客户的信任和合作机会，在多个关键市场取得 了销售增长。(3)2025年度，公司与广东横琴甘瓴企业管理有限责任公司(以下简称"横琴甘瓴")达成一致 协议，公司将全资子公司甘甘医疗科技江苏有限公司(以下简称"甘甘江苏")合计70%的股权分两步转让 予横琴甘瓴。2025年度，公司已完成首步交易，成功转让甘甘江苏55%的股权，投资收益增加，使公司 净利润增加。 智通财经APP讯，甘李药业(603087.SH)发布2025年年度业绩预增公告，预计2025年年度实现归属于母 公司所有者的净利润为11.00亿元到12.00亿元，与上年同期(法定披露数据)相比，将增加4.85亿元到5.85 亿元，同比增加78.96%到95.23%。 ...

2025年度，公司预计归属于母公司所有者的净利润较去年同期实现大幅增长，主要受益于国内外收入增 长、股权转让收益。(1)在国内市场，公司在集采获得的市场覆盖优势上，不断深耕和拓宽市场，胰岛 素制剂产品的销量与销售额同步实现大幅增长。(2)在国际市场，公司积极推进国际化战略，在"一带一 路"沿线及新兴市场拓展成效显著，成功赢得了更多国际客户的信任和合作机会，在多个关键市场取得 了销售增长。(3)2025年度，公司与广东横琴甘瓴企业管理有限责任公司(以下简称"横琴甘瓴")达成一致 协议，公司将全资子公司甘甘医疗科技江苏有限公司(以下简称"甘甘江苏")合计70%的股权分两步转让 予横琴甘瓴。2025年度，公司已完成首步交易，成功转让甘甘江苏55%的股权，投资收益增加，使公司 净利润增加。 甘李药业（603087）(603087.SH)发布2025年年度业绩预增公告，预计2025年年度实现归属于母公司所 有者的净利润为11.00亿元到12.00亿元，与上年同期(法定披露数据)相比，将增加4.85亿元到5.85亿元， 同比增加78.96%到95.23%。 ...

Group 1: Profit Forecasts - Limin Co. expects a net profit of 465 million to 500 million yuan for 2025, representing a year-on-year increase of 471.55% to 514.57% [1] - Guohui Energy anticipates a net profit of 1.32 billion to 1.47 billion yuan for 2025, reflecting a decline of 50.03% to 55.13% year-on-year [2] - Jiajia Yue forecasts a net profit of 198 million to 228 million yuan for 2025, indicating a growth of 50.06% to 72.79% year-on-year [3] - Xianghe Industry projects a net profit of 120 million to 148 million yuan for 2025, with an expected increase of 59.17% to 96.31% year-on-year [4] - Aojie Technology predicts a net profit of 90 million to 120 million yuan for 2025, showing a growth of 228.34% to 337.79% year-on-year [14] - Shanghai Electric expects a net profit of 1.1 billion to 1.32 billion yuan for 2025, representing an increase of approximately 47% to 76% year-on-year [15] - Tianfu Communication anticipates a net profit of 1.881 billion to 2.15 billion yuan for 2025, reflecting a growth of 40% to 60% year-on-year [16] - Yichang Technology forecasts a net profit of 150 million to 225 million yuan for 2025, indicating a year-on-year increase of 58% to 138% [29] - Shanghai Yizhong expects a net profit of 60 million to 70 million yuan for 2025, representing a significant increase of 760.18% to 903.54% year-on-year [41] Group 2: Loss Forecasts - Kexin Electromechanical anticipates a net profit of 55 million to 70 million yuan for 2025, reflecting a decline of 58.65% to 67.51% year-on-year [11][12] - Kexin Technology expects a net loss of 900 million to 1.2 billion yuan for 2025, which is an increase in loss of 78.67% to 84% year-on-year [10] - Tianyang New Materials forecasts a net loss of 250 million to 180 million yuan for 2025, compared to a loss of 213 million yuan in the previous year [20] - Bo Rui Data anticipates a net loss of 90 million to 100 million yuan for 2025, which is an increase in loss of 15.17 million to 25.17 million yuan year-on-year [19] - Xinlian Integrated expects a net loss of 577 million yuan for 2025, which is a reduction in loss of approximately 40.02% compared to the previous year [40] - Fangshilong forecasts a net loss of 4 million to 6 million yuan for 2025 [30] Group 3: Strategic Developments - Lianlong signed a strategic framework agreement with Runyinglian to enhance the reliability and efficiency of the lubricant additive supply chain in China and the Asia-Pacific region [7] - Han Jian Heshan is planning to acquire a 52.51% stake in Liaoning Xingfu New Materials Co., Ltd., with stock suspension expected for up to 9 trading days [13] - Kai Zhong Precision plans to invest 116 million yuan in a technical transformation and expansion project to meet future capacity demands [34] - Tianfu Communication is expected to engage in clinical trials for its ABA001 injection, which has received approval from the National Medical Products Administration [17]

海利得（002206）(002206.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净利润5亿元至 5.4亿元，同比增长21.78%-31.53%;扣除非经常性损益后的净利润5.3亿元至5.7亿元，同比增长 32.47%-42.47%。 ...

Group 1 - The company, Hailide (002206.SZ), has disclosed its performance forecast for the year 2025, expecting a net profit attributable to shareholders of 500 million to 540 million yuan, representing a year-on-year growth of 21.78% to 31.53% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 530 million and 570 million yuan, indicating a year-on-year increase of 32.47% to 42.47% [1]